In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.
The commercialisation of quantum science in pharma
Conference report: Reuters Pharma Europe
In vitro gametogenesis: the science has to be right, and it has to be safe
Proving ROI for digital endpoints
Clinical trials: their design, location, and, potentially, their simulation
Pace, acceleration, and precision are the name of the game
Technology working as the puzzle piece to bring better outcomes to patients
Is precision psychiatry possible?
Encouraging early engagement to revitalise Europe’s pharmaceutical landscape
Predictions for AI in mental health in the coming year
Fixing clinical trial data management
Harnessing the velocity of biopharmaceutical advances
Conference report: Reuters Pharma USA
The future of AI: Machine learning working together with scientific expertise
Understanding the politics of drug pricing in the United States
Female leadership and lessening disease burden
The unique clinical trial challenges faced by digital therapeutics
The unmentionables: Challenging inequalities in women’s health
The next chapter for AI protein structure prediction
Avoiding the data swamp: The transformative power of AI
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Stuff To Blow Your Mind
Ground Truths